Home >> Top News >> Sofia Strep A+ Assay lands FDA 510(k) clearance

Sofia Strep A+ Assay lands FDA 510(k) clearance

Print Friendly, PDF & Email

Jan. 5, 2018Quidel received 510(k) clearance and CLIA waiver from the FDA for its Sofia Strep A+ Fluorescent Immunoassay (FIA) for use with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid detection of infections by group A streptococcus bacteria. Sofia Strep A+ is the third CLIA-waived assay available on the Sofia 2 system, following the Sofia Influenza A+B and Sofia RSV assays.

More top news

x

Check Also

FDA clears POC Sofia Lyme FIA for Sofia 2

March 15, 2018—Quidel received 510(k) clearance from the FDA to market its Sofia Lyme FIA...

X